Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Lancet (London, England)
|
November 29, 2020
Ruxolitinib cream for the treatment of vitiligo
Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
The Journal of Dermatological Treatment
|
November 6, 2019
Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapy
Vipawee S Chat, Donovan G Kearns, Shelley K Uppal, et al.
The Journal of Dermatological Treatment
|
June 23, 2020
Clinical management of psoriasis patients during the COVID-19 pandemic
Vipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Journal of Drugs in Dermatology : JDD
|
July 7, 2021
Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2
Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Lancet (London, England)
|
January 17, 2021
Abrocitinib for atopic dermatitis
Shelley K Uppal, Vipawee S Chat, Donovan G Kearns, et al.
Cutis
|
January 19, 2021
Dermatologists as social media contributors during the COVID-19 pandemic
Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Cutis
|
September 17, 2020
Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis With Phototherapy
Donovan G Kearns, Shelley Uppal, Vipawee S Chat, et al.
Cutis
|
October 11, 2022
Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice
Vipawee S Chat, Donovan G Kearns, Shelley K Uppal, et al.
Cutis
|
October 18, 2021
Translating the 2019 AAD-NPF Guidelines of Care for Psoriasis With Attention to Comorbidities
Vipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Cutis
|
April 23, 2021
Translating the 2020 AAD-NPF Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologics to Clinical Practice
Vipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Lancet (London, England)
|
November 29, 2020
Ruxolitinib cream for the treatment of vitiligo
Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
The Journal of Dermatological Treatment
|
November 6, 2019
Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapy
Vipawee S Chat, Donovan G Kearns, Shelley K Uppal, et al.
The Journal of Dermatological Treatment
|
June 23, 2020
Clinical management of psoriasis patients during the COVID-19 pandemic
Vipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Journal of Drugs in Dermatology : JDD
|
July 7, 2021
Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2
Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Lancet (London, England)
|
January 17, 2021
Abrocitinib for atopic dermatitis
Shelley K Uppal, Vipawee S Chat, Donovan G Kearns, et al.
Cutis
|
January 19, 2021
Dermatologists as social media contributors during the COVID-19 pandemic
Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Cutis
|
September 17, 2020
Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis With Phototherapy
Donovan G Kearns, Shelley Uppal, Vipawee S Chat, et al.
Cutis
|
October 11, 2022
Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice
Vipawee S Chat, Donovan G Kearns, Shelley K Uppal, et al.
Cutis
|
October 18, 2021
Translating the 2019 AAD-NPF Guidelines of Care for Psoriasis With Attention to Comorbidities
Vipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Cutis
|
April 23, 2021
Translating the 2020 AAD-NPF Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologics to Clinical Practice
Vipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Page
of 3